alexa Patient Centric Drug Product Design: Improving Drug Safety And Effectiveness
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Summit on Clinical Pharmacy
December 02-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Sven Stegemann
ScientificTracks Abstracts: Clinic Pharmacol Biopharm
DOI: 10.4172/2167-065X.S1.006
Abstract
Since decades pharmaceutical drug products are developed in traditional dosage form like capsules and tablets as well as injectables, transdermal and inhalation systems. However, significant advances have been made through drug delivery technologies that make nearly each product a unique therapeutic system with product specific requirements for use and administration. As majority of people are lay persons and the drug products still look alike each other medication errors and inappropriate alteration have been identified as a growing area of concerns for drug safety and efficacy. Patient information leaflets trying to make the patients fit the product have achieved only limited improvement as the heath literacy is often insufficient in the general patient population. Patient centric drug product design aims to increase drug product safety and effectiveness through a solid understanding and integration of patient needs and capabilities to design the pharmaceutical products that they are intuitively used as intended like smart phones and other products from the consumer industry.Factors that need to be considered in the design of patient centric products are based on the targeted patient population. The major areas that are taken into account are the cognitive, sensory, motoric and swallowing capabilities of the patient, but also the prediction of the context in which these drug therapies will be applied e.g. disease clusters and predicted co-morbidities. Based on this, the design features are determined for a specific product to make it most suited for the targeted patient increasing safety and effectiveness to the benefit of the patient and society.
Biography
Sven Stegemann is a pharmacist by training and holds a PhD in pharmacology. He started his career at Sanofi-Aventis working in different roles of the pharmaceutical product development and manufacturing cycle. Before joining Capsugel, he worked for AstaMedica where he was responsible for product licensing. Since 1997, he is Director for Pharmaceutical Business Development at Capsugel. Within this role he is leading common research projects with all major pharmaceutical as well as SME companies on a global base.Within the pharmaceutical community he is serving different organizations as president, chairman or committee member. Beside his professional tasks he is substantially engaged in Education & Training in academy and through high level conferences across the world and special engagement within the European Commission to support strengthening the life sciences in Europe.His scientific interest is in improving drug therapy in older adults through multidisciplinary and patient centered research. Recently he founded the Geriatric Medicines Society e.V., which is supported by industry, academia and regulatory authorities. Another area of scientific interest is the delivery of affordable medicines through simplified product design and manufacturing.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords